SCHEMBL14964347

SCHEMBL14964347

CC(C)(C)[C@H](NC(=O)c1cc2ccccc2[nH]1)C(=O)N1C[C@@H]2C[C@H]1CN2C(=O)O

nearest known ligand 0.48

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
DRD2 P14416 1/20 0.47
CYP51A1 Q16850 1/20 0.45
STAT6 P42226 1/20 0.44
PYGL P06737 1/20 0.42
NPC1 O15118 1/20 0.42
LMNA P02545 1/20 0.42
RAB9A P51151 1/20 0.42
SMN1; SMN2 Q16637 1/20 0.42
CNR2 P34972 1/20 0.42
CCKBR P32239 3/20 0.42
TAS1R3 Q7RTX0 1/20 0.41
TAS1R1 Q7RTX1 1/20 0.41
GAA P10253 2/20 0.41
KDM4E B2RXH2 1/20 0.41
ALDH1A1 P00352 1/20 0.41
MAPK1 P28482 1/20 0.41
CCKAR P32238 1/20 0.41
HPGD P15428 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1931683 0.92 DRD2 (0.47) DRD2CYP51A1STAT6PYGLCNR2
SCHEMBL1931738 0.92 DRD2 (0.47) DRD2CYP51A1STAT6PYGLCNR2
SCHEMBL1931303 0.92 DRD2 (0.47) DRD2CYP51A1STAT6PYGLCNR2
SCHEMBL19856894 0.92 DRD2 (0.45) DRD2CYP51A1STAT6PYGLNPC1
SCHEMBL19856892 0.92 DRD2 (0.45) DRD2CYP51A1STAT6PYGLNPC1
SCHEMBL1929666 0.89 PARP1 (0.45) DRD2CYP51A1STAT6CNR2TAS1R3
SCHEMBL19856921 0.88 CYP51A1 (0.43) DRD2CYP51A1STAT6PYGLCCKBR
SCHEMBL19856919 0.88 CYP51A1 (0.43) DRD2CYP51A1STAT6PYGLCCKBR
SCHEMBL19856906 0.88 DRD2 (0.45) DRD2CYP51A1STAT6PYGLCCKBR
SCHEMBL8000170 0.88 DRD2 (0.46) DRD2CYP51A1STAT6PYGLCNR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2312947-B1 TRPV4 ANTAGONISTS GLAXOSMITHKLINE LLC (US) 2014-01-01 EP disclosed
US-8450484-B2 TRPV4 antagonists GlaxoSmithKline, LLC (US) 2013-05-28 US disclosed